v3.26.1
Insider Trading Arrangements
shares in Thousands
3 Months Ended
Jun. 30, 2026
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
From time to time, our officers (as defined in Rule 16a-1(f)) and directors may enter into, amend or terminate Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the second quarter of 2026, our officers and directors took the following actions with respect to trading arrangements:
Trading Arrangement
Name and PositionActionDateRule
10b5-1
Non-Rule 10b5-1Total Shares to be Purchased or SoldExpiration Date
Priya Singhal, M.D., EVP, Head of Development(1)
Adopt4/30/2026X20,40010/29/2027
Lloyd Minor, Director
Adopt5/4/2026X5938/7/2026
(1) Dr. Singhal's Rule 10b5-1 trading arrangement provides for the sale of (i) up to 20,400 shares of our common stock and (ii) all of the shares of our common stock to be acquired under our Employee Stock Purchase Plan during the term of the 10b5-1 trading arrangement. The number of shares to be acquired under the plan is not determinable at this time as the purchase price for such shares will be determined at the end of the applicable purchase period under the plan.
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Priya Singhal [Member]  
Trading Arrangements, by Individual  
Name Priya Singhal, M.D.
Title EVP, Head of Development
Rule 10b5-1 Arrangement Adopted true
Adoption Date 4/30/2026
Expiration Date 10/29/2027
Arrangement Duration 547 days
Aggregate Available 20,400,000
Lloyd Minor [Member]  
Trading Arrangements, by Individual  
Name Lloyd Minor
Title Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date 5/4/2026
Expiration Date 8/7/2026
Arrangement Duration 95 days
Aggregate Available 593,000